Perspectives on the draft ICH M10 guidance: an interview with John Kadavil

In this Bioanalysis Zone interview, John Kadavil (US FDA; MA, USA) shares his thoughts on the draft ICH M10 guidance for bioanalytical method validation, indicating how easy it will be for laboratories to adapt to implement the guidance and how this will change the bioanalytical regulatory landscape. John ends by discussing the future perspective of the collective consensus guidance.   If you enjoyed this interview, you might also like… Panel discussion: ICH M10 draft bioanalytical method validation guideline FDA announces final guidance for ’Bioanalytical Method validation,’ now available Panel discussion: FDA guidance, transitioning skills and future hopes for the bio...

To view this content, please register now for access

It's completely free